Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BVMF/T1EV34 stock hub

BVMF/T1EV34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/T1EV34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

203.8B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/T1EV34

In the news

Latest news · BVMF/T1EV34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 11.3P50 14.6P75 19.6

Trailing P/E25

P25 15.2P50 21.5P75 27.3

ROE21.6

P25 5.3P50 12.3P75 22.5

ROIC18.6

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/T1EV34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

USD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	BR
Employees	32,842
Employees Change	-2,844%
Employees Change Percent	-7.97
Enterprise value	BRL 268.4B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	BRL 203.8B
Price	BRL 89.46
Price currency	BRL
Rev Per Employee	2,827,573.17x
Sector	Healthcare
Sic	2834
Symbol	bvmf/T1EV34
Website	https://www.tevapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.01%
EV Earnings	32.87x
EV/EBIT	13.63x
EV/EBITDA	10.64x
EV/FCF	43.89x
EV/Sales	3.16x
FCF yield	3%
Forward P/E	14.57x
P/B ratio	4.74x
P/E ratio	24.96x
P/S ratio	2.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.09%
EBITDA Margin	28.84%
FCF margin	6.76%
Gross margin	52.06%
Gross Profit	BRL 47.1B
Gross Profit Growth	10.56%
Gross Profit Growth Q	5.01%
Gross Profit Growth3 Y	9.84%
Gross Profit Growth5 Y	3.67%
Net Income	BRL 8.2B
Net Income Growth Q	72.43%
Pretax Margin	7.95%
Profit Margin	9.02%
Profit Per Employee	BRL 255,067
ROA	6.38
Roa5y	4.67
ROCE	15.11
ROE	21.6
Roe5y	-7.19
ROIC	18.63
Roic5y	12.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	101.77%
Cagr3y	60.23%
EPS Growth Q	72.22
FCF Growth	53.2%
FCF Growth3 Y	6.73%
OCF Growth	35.39%
OCF Growth10 Y	-11.11%
OCF Growth3 Y	4.69%
OCF Growth5 Y	27.64%
Revenue Growth	4.41x
Revenue Growth Q	2.34x
Revenue Growth3 Y	5.14x
Revenue Growth5 Y	1.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.44
Assets	BRL 208.9B
Cash	BRL 19.5B
Current Assets	BRL 67.4B
Current Liabilities	BRL 66.5B
Debt	BRL 88.3B
Debt EBITDA	BRL 3.29
Debt Equity	BRL 2.06
Debt FCF	BRL 14.44
Equity	BRL 42.9B
Interest Coverage	4.48
Liabilities	BRL 165.9B
Long Term Assets	BRL 141.5B
Long Term Liabilities	BRL 99.4B
Net Cash	BRL -68.8B
Net Cash By Market Cap	BRL -33.75
Net Debt EBITDA	BRL 2.64
Net Debt Equity	BRL 1.6
Net Debt FCF	BRL 11.25
Tangible Book Value	BRL -58.4B
Tangible Book Value Per Share	BRL -50.19
WACC	7.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Inventory Turnover	2.59
Net Working Capital	BRL -5B
Quick ratio	0.53
Working Capital	BRL 928.6M
Working Capital Turnover	BRL 330

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.93%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	101.67%
200-day SMA	57.72
3Y total return	311.5%
50-day SMA	77.69
50-day SMA vs 200-day SMA	50over200
All Time High	97.29
All Time High Change	-8.05%
All Time High Date	2026-02-03
All Time Low	17.8
All Time Low Change	402.58%
All Time Low Date	2023-06-02
ATR	2.54
Beta	0.76
Ch YTD	5.9
High	89.46
High52	97.29
High52 Date	2026-02-03
High52ch	-8.05%
Low	89.46
Low52	42.67
Low52 Date	2025-08-01
Low52ch	109.66%
Ma50ch	15.16%
Price vs 200-day SMA	55%
RSI	61.97
RSI Monthly	70.45
RSI Weekly	68.52
Sharpe ratio	1.71x
Sortino ratio	3.25
Total Return	-2.93%
Tr YTD	5.9
Tr1m	19.09%
Tr1w	2.47%
Tr3m	-1.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 20.9B
Operating Income Growth	17.07
Operating Income Growth Q	7.62
Operating Income Growth3 Y	17.08
Operating Income Growth5 Y	6.92
Operating margin	23.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,083,200,880%
Net Borrowing	-2,304,759,800
Shares Qo Q	0.51%
Shares Yo Y	2.93%
Short Ratio	4.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 5.2B
Average Volume	310.15x
Bv Per Share	36.86
CAPEX	BRL -2.8B
Ch1m	19.09
Ch1w	2.47
Ch1y	101.7
Ch3m	-1.91
Ch3y	311.5
Ch6m	37.1
Change	2.47%
Change From Open	0
Close	87.3
Days Gap	2.47
Depreciation Amortization	4,899,457,400
Dollar Volume	805.1
Earnings Date	2026-04-29
EBIT	BRL 20.9B
EBITDA	BRL 26.1B
EPS	BRL 6.99
F Score	7
FCF	BRL 6.1B
FCF EV Yield	2.28x
Financing CF	-2,055,389,650
Fiscal Year End	December
Founded	1,901
Goodwill	77,752,472,400
Graham Number	38.99414
Graham Upside	-56.41
Income Tax	BRL -975.5M
Investing CF	3,990,794,625
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	60.51
Ma150ch	47.83%
Ma20	84.91
Ma20ch	5.35%
Net CF	10,662,985,900
Open	89.46
P FCF Ratio	33.33
P OCF Ratio	22.79
Ppne	21,293,228,600
Price Date	2026-05-06
Price EBITDA	BRL 7.81
Relative Volume	0.03x
Revenue	90,504,962,025x
SBC By Revenue	0.96x
Share Based Comp	865,976,350
Tax By Revenue	-1.08x
Tr6m	37.1%
Volume	9
Z Score	0.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/T1EV34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/T1EV34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/T1EV34?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/T1EV34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.0

Neutral momentum band

Price vs 200-day MA

+55.0%

50/200-day relationship not available

Beta (5Y)

0.76

Less volatile than the market

Sharpe ratio

1.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/T1EV34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/T1EV34 stock rating?

bvmf/T1EV34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/T1EV34 analysis?

The full report lives at /stocks/bvmf/T1EV34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/T1EV34?

The latest report frames bvmf/T1EV34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/T1EV34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.